Anavex Life Sciences Corp (AVXL)

[dadbrotheroftwins]

The primary endpoints have not been met, otherwise they would have been released at CTAD. They weren't, so Dr. M will have to make the rest of the stat's look good. It's taking time to dress them up, so people are believing that things are not all that great, so retail is selling, and shorts are taking advantage. It could go below $3 before Rett readout which will be next year sometime, and then it needs to be outstanding and meet the primary endpoint. Hopefully Dr. M can design a trial where the primary endpoint is achievable for the next PDD trial.